# Effect of Short-Term and Long-Term Non-Physiological T3 Concentrations on Cardiac Stromal Cells: From Cellular Response to In Vivo Adaptation

**Authors:** Ahmad Alhamid, Yoshishige Urata, Kodai Nishi, Hiroshi Kurazumi, Ryo Suzuki, Koji Ueno, Akihito Mikamo, Kimikazu Hamano, Tao-Sheng Li

PMC · DOI: 10.3390/medsci14010066 · Medical Sciences · 2026-01-31

## TL;DR

This study shows how abnormal thyroid hormone levels affect heart cells, causing short-term changes in cell growth and metabolism that eventually return to normal.

## Contribution

The study reveals the acute and transient effects of non-physiological T3 levels on cardiac stromal cells and their alignment with in vivo metabolic responses.

## Key findings

- Non-physiological T3 levels cause acute increases in cardiac stromal cell proliferation and ECM-related gene expression.
- Cardiac glucose uptake increases in acute hypothyroidism and decreases in acute hyperthyroidism, normalizing with chronic exposure.
- Changes in gene expression and metabolism are transient and return to baseline after prolonged exposure to altered T3 levels.

## Abstract

Background/Objectives: Epidemiological and clinical studies have linked both hypothyroidism and hyperthyroidism to adverse cardiac outcomes, including heart failure and myocardial fibrosis. Triiodothyronine (T3), a biologically active thyroid hormone, is important for cardiovascular homeostasis. While the effects of physiological and non-physiological T3 levels on cardiomyocytes have been extensively investigated, the impact of hypothyroidism and hyperthyroidism on cardiac stromal cells (CSCs), which constitute the majority of the cells in the heart, remains understudied. Given CSCs’ essential role in extracellular matrix (ECM) remodeling and paracrine signaling, understanding their response to altered T3 states is necessary to fully elucidate the thyroid hormone-induced cardiac responses. Methods: Cardiac stromal cells were isolated from human atrial appendages and cultured under hypothyroid (0 nM T3), euthyroid (2.5 nM T3), and hyperthyroid (25 nM T3) conditions for 24 (short term) and 120 h (long term). The cells were harvested after 24 h of treatment using trypsin and automatically counted, and their ECM-related gene and growth factor expression levels were assessed using quantitative RT-PCR. Cardiac glucose uptake in hypothyroid, euthyroid, and hyperthyroid mice was monitored using [18F]-FDG PET/CT at acute (7 days) and chronic (42 days) time points. Results: Both hypo- and hyperthyroidism significantly increased the number of CSCs harvested after 24 h. There were acute alterations in the expression of the ECM-related genes COL1A1, COL3A1, TIMP3 (p < 0.05), and TIMP1 (p < 0.01). Similarly, growth factors such as PDGF-A (p < 0.001), TGF-b, and IGF1 (p < 0.05) were transiently upregulated under non-physiological T3 conditions, especially hypothyroidism. Most of these alterations were attenuated or reversed at the 120 h time point. In vivo PET imaging revealed significant increases in cardiac glucose uptake under acute hypothyroidism (p < 0.05) and decreases under acute hyperthyroidism (p < 0.05). However, these metabolic shifts normalized with chronic exposure, paralleling the transient nature of the gene expression changes observed in vitro. Conclusions: Non-physiological T3 concentrations induce proliferation and changes in ECM-related and growth factor gene expression in CSCs. Most of these changes are acute and return to normal levels after chronic exposure. These transient cellular responses correlate closely with the cardiac metabolic response patterns to acute and chronic hypothyroidism and hyperthyroidism.

## Linked entities

- **Genes:** COL1A1 (collagen type I alpha 1 chain) [NCBI Gene 1277], COL3A1 (collagen type III alpha 1 chain) [NCBI Gene 1281], TIMP3 (TIMP metallopeptidase inhibitor 3) [NCBI Gene 7078], TIMP1 (TIMP metallopeptidase inhibitor 1) [NCBI Gene 7076], PDGFA (platelet derived growth factor subunit A) [NCBI Gene 5154], TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040], IGF1 (insulin like growth factor 1) [NCBI Gene 3479]
- **Chemicals:** T3 (PubChem CID 5920), [18F]-FDG (PubChem CID 68614)
- **Diseases:** heart failure (MONDO:0005252), hypothyroidism (MONDO:0005420), hyperthyroidism (MONDO:0004425)
- **Species:** Homo sapiens (taxon 9606), Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Dio1 (deiodinase, iodothyronine, type I) [NCBI Gene 13370] {aka 5DI, D1, ITDI1, TXDI1}, Pdgfa (platelet derived growth factor, alpha) [NCBI Gene 18590] {aka PDGF-1}, COL3A1 [NCBI Gene 101099823], Timp2 (tissue inhibitor of metalloproteinase 2) [NCBI Gene 21858] {aka D11Bwg1104e, Timp-2}, Fgf2 (fibroblast growth factor 2) [NCBI Gene 14173] {aka Fgf-2, Fgf2a, Fgfb, bFGF}, Mmp2 (matrix metallopeptidase 2) [NCBI Gene 17390] {aka Clg4a, GelA, MMP-2}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, TIMP-4 [NCBI Gene 101094660], TIMP3 (TIMP metallopeptidase inhibitor 3) [NCBI Gene 7078] {aka HSMRK222, K222, K222TA2, SFD}, Fn1 (fibronectin 1) [NCBI Gene 14268] {aka E330027I09, Fn, Fn-1}, Hgf (hepatocyte growth factor) [NCBI Gene 15234] {aka C230052L06Rik, HGF/SF, NK1, NK2, SF, SF/HGF}, Col4a1 (collagen, type IV, alpha 1) [NCBI Gene 12826] {aka Bru, Col4a-1, Raw, Svc}, COL3A1 (collagen type III alpha 1 chain) [NCBI Gene 1281] {aka EDS4A, EDSVASC, PMGEDSV}, Egf (epidermal growth factor) [NCBI Gene 13645], TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, Th (tyrosine hydroxylase) [NCBI Gene 21823], IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}, COL1A1 [NCBI Gene 101092216], COL1A1 (collagen type I alpha 1 chain) [NCBI Gene 1277] {aka CAFYD, EDSARTH1, EDSC, OI1, OI2, OI3}, Ccnd1 (cyclin D1) [NCBI Gene 12443] {aka CycD1, Cyl-1, PRAD1, bcl-1, cD1}, Timp1 (tissue inhibitor of metalloproteinase 1) [NCBI Gene 21857] {aka Clgi, EPA, TIMP-1, TPA-S1, Timp}, Dio2 (deiodinase, iodothyronine, type II) [NCBI Gene 13371] {aka 5DII, DIOII}, TIMP-3 [NCBI Gene 101091215], Dio3 (deiodinase, iodothyronine type III) [NCBI Gene 107585], TIMP1 (TIMP metallopeptidase inhibitor 1) [NCBI Gene 7076] {aka CLGI, EPA, EPO, HCI, TIMP, TIMP-1}, FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Igf1 (insulin-like growth factor 1) [NCBI Gene 16000] {aka C730016P09Rik, Igf-1, Igf-I}, PDGFA (platelet derived growth factor subunit A) [NCBI Gene 5154] {aka PDGF-A, PDGF1}
- **Diseases:** thyroid (MESH:D013966), thyroid hormone (MESH:D018382), Heart failure (MESH:D006333), cardiomyopathy (MESH:D009202), coronary artery disease (MESH:D003324), Hyperthyroidism (MESH:D006980), myocardial infarction (MESH:D009203), biventricular dilation (MESH:D002311), Atrial fibrillation (MESH:D001281), ischemic injury (MESH:D017202), elevated cardiac output (MESH:D002303), cancer (MESH:D009369), euthyroidism (MESH:D005067), injury to (MESH:D014947), cardiac fibrosis (MESH:D005355), left ventricular hypertrophy (MESH:D017379), hyper- and hypothyroidism (MESH:D007037), pulmonary arterial hypertension (MESH:D000081029)
- **Chemicals:** noradrenaline (MESH:D009638), T3 (MESH:D014284), glucose (MESH:D005947), NaOH (MESH:D012972), reactive oxygen species (MESH:D017382), TH (MESH:D013910), butorphanol (MESH:D002077), isoflurane (MESH:D007530), MTT (MESH:C070243), 18F-FDG (MESH:D019788), fatty acid (MESH:D005227), CellTiter-Glo (-), medetomidine (MESH:D020926), glycosaminoglycans (MESH:D006025), midazolam (MESH:D008874), charcoal (MESH:D002606)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12921974/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12921974/full.md

## References

36 references — full list in the complete paper: https://tomesphere.com/paper/PMC12921974/full.md

---
Source: https://tomesphere.com/paper/PMC12921974